Stroma‐directed imatinib therapy impairs the tumor‐promoting effect of bone marrow‐derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Bone marrow‐derived mesenchymal stem cells (MSCs) are reported to contribute to formation of tumor‐promoting stromal cells. We reported recently that, in an orthotopic nude mice model of colon cancer, MSCs traveled to tumor stroma, where they differentiated into carcinoma‐associated fibroblast (CAF)‐like cells. We also found that CAFs express platelet‐derived growth factor receptor (PDGFR) at a high level and that imatinib therapy targeting PDGFR in CAFs inhibits growth and metastasis of human colon cancer. These findings led us to examine whether the tumor‐promoting effect of MSCs is impaired by blockade of PDGFR signaling achieved with imatinib. Orthotopic transplantation and splenic injection of human MSCs along with KM12SM human colon cancer cells, in comparison with transplantation of KM12SM cells alone, resulted in significantly greater promotion of tumor growth and liver metastasis. The KM12SM + MSC xenograft enhanced cell proliferation and angiogenesis and inhibited tumor cell apoptosis. When tumor‐bearing animals were treated with imatinib, there was no significant increase in primary tumor volume or total volume of liver metastases, despite the KM12SM+MSC xenograft, and survival in the mixed‐cell group was prolonged by imatinib treatment. Moreover, the ability of MSCs to migrate to tumor stroma was impaired, and the number of MSCs surviving in the tumor microenvironment was significantly decreased. In in vitro experiments, treatment with imatinib inhibited migration of MSCs. Our data suggest that blockade of PDGF signaling pathways influences the interaction between bone marrow‐derived MSCs and tumor cells in the tumor microenvironment and, hence, inhibits the progressive growth of colon cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noël, D., & Jorgensen, C. (2003) · Blood · doi:10.1182/blood-2003-04-1193 · Cited by 1,166
Role of tissue stroma in cancer cell invasion
De Wever, O., & Mareel, M. (2003) · The Journal of Pathology · doi:10.1002/path.1398 · Cited by 1,042
Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblasts
Zeisberg, E. M., Potenta, S., Xie, L., Zeisberg, M., & Kalluri, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-3127 · Cited by 1,011
Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells
Mishra, P. J., Mishra, P. J., Humeniuk, R., Medina, D. J., Alexe, G., Mesirov, J. P., Ganesan, S., Glod, J. W., & Banerjee, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0943 · Cited by 912
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
Nakamura, K., Ito, Y., Kawano, Y., Kurozumi, K., Kobune, M., Tsuda, H., Bizen, A., Honmou, O., Niitsu, Y., & Hamada, H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302276 · Cited by 597
Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts
Direkze, N. C., Hodivala-Dilke, K., Jeffery, R., Hunt, T., Poulsom, R., Oukrif, D., Alison, M. R., & Wright, N. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1708 · Cited by 530
Ramasamy, R., Lam, E. W.-F., Soeiro, I., Tisato, V, Bonnet, D., & Dazzi, F. (2007) · Leukemia · doi:10.1038/sj.leu.2404489 · Cited by 404
Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo
Zhu, W., Xu, W., Jiang, R., Qian, H., Chen, M., Hu, J., Cao, W., Han, C., & Chen, Y. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.07.004 · Cited by 386
Research works printed but not linked: 36
- 10.1038/nature07205 · DOI · Paper page
- Kitadai Y, 2009, Cancer‐stromal cell interaction and tumor angiogenesis in gastric cancer, Cancer Microenviron
- 10.2353/ajpath.2006.060653 · DOI
- 10.1002/ijc.22229 · DOI · Paper page
- 10.1016/j.cell.2005.02.034 · DOI · Paper page
- 10.1002/ijc.25812 · DOI · Paper page
- 10.1038/nrc1877 · DOI · Paper page
- 10.1002/jor.1100090504 · DOI · Paper page
- 10.1016/j.yexcr.2005.03.018 · DOI · Paper page
- Studeny M, 2002, Bone marrow‐derived mesenchymal stem cells as vehicles for interferon‐beta delivery into tumors, Cancer Res, 62, 3603
- 10.1158/0008-5472.CAN-04-1874 · DOI · Paper page
- 10.1634/stemcells.2006-0257 · DOI · Paper page
- 10.1038/sj.bjc.6604508 · DOI · Paper page
- 10.1038/sj.cgt.7701097 · DOI
- 10.1158/1078-0432.CCR-07-0731 · DOI · Paper page
- 10.1158/0008-5472.CAN-07-1406 · DOI · Paper page
- 10.1002/jcb.10763 · DOI · Paper page
- 10.1158/0008-5472.CAN-08-3562 · DOI · Paper page
- 10.1158/0008-5472.CAN-10-0538 · DOI · Paper page
- 10.1158/0008-5472.CAN-10-1254 · DOI · Paper page
- 10.1016/j.ccr.2011.01.020 · DOI · Paper page
- 10.3727/096368909X471134 · DOI
- 10.1172/JCI9083 · DOI · Paper page
- 10.1016/j.bbrc.2005.04.118 · DOI · Paper page
- Morikawa K, 1988, Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice, Cancer Res, 48, 6863
- Hwang RF, 2003, Inhibition of platelet‐derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model, Clin Cancer Res, 9, 6534
- 10.1073/pnas.90.2.393 · DOI · Paper page
- 10.1016/j.lungcan.2004.07.977 · DOI · Paper page
- 10.2353/ajpath.2009.081030 · DOI · Paper page
- 10.1073/pnas.95.3.1050 · DOI · Paper page
- 10.3892/ijo_00000680 · DOI
- Pietras K, 2001, Inhibition of platelet‐derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors, Cancer Res, 61, 2929
- 10.1053/j.seminoncol.2004.03.036 · DOI
- 10.1016/j.bmc.2010.08.026 · DOI
- Hibi K, 1991, Coexpression of the stem cell factor and the c‐kit genes in small‐cell lung cancer, Oncogene, 6, 2291
- 10.1186/1476-4598-5-46 · DOI
Cited by
Mesenchymal Stem Cell Migration and Tissue Repair
Fu, X., Liu, G., Halim, A., Ju, Y., Luo, Q., & Song, G. (2019) · Cells · doi:10.3390/cells8080784 · Cited by 1,044
Targeting the PDGF signaling pathway in tumor treatment
Heldin, C.-H. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-97 · Cited by 540
Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets
Shi, Y., Du, L., Lin, L., & Wang, Y. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.193 · Cited by 460
Nagasaki, T., Hara, M., Nakanishi, H., Takahashi, H., Sato, M., & Takeyama, H. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.748 · Cited by 385
Cancer stem cells in progression of colorectal cancer
Zhou, Y., Xia, L., Wang, H., Oyang, L., Su, M., Liu, Q., Lin, J., Tan, S., Tian, Y., Liao, Q., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.23607 · Cited by 298
Metadata
- Authors
- Shinagawa, K., Kitadai, Y., Tanaka, M., Sumida, T., Onoyama, M., Ohnishi, M., Ohara, E., Higashi, Y., Tanaka, S., Yasui, W., & Chayama, K.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2012-08-06
- Volume
- 132
- Issue
- 4
- Pages
- 813-823
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2104693167
- Cited by
- 79
- References
- 14
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stroma‐directed imatinib therapy impairs the tumor‐promoting effect of bone marrow‐derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer. https://app.cochat.ai/papers/10.1002/ijc.27735
- The paper
- Shinagawa, K., Kitadai, Y., Tanaka, M., Sumida, T., Onoyama, M., Ohnishi, M., Ohara, E., Higashi, Y., Tanaka, S., Yasui, W., & Chayama, K. (2013). Stroma‐directed imatinib therapy impairs the tumor‐promoting effect of bone marrow‐derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.27735
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.